Accedi

È necessario avere un abbonamento a JoVE per visualizzare questo. Accedi o inizia la tua prova gratuita.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Adeno-associated virus is produced in suspension cell culture and purified by double iodixanol density gradient centrifugation. Steps are included to increase total virus yield, decrease the risk of virus precipitation, and further concentrate the final virus product. Expected final titers reach 1012 viral particles/mL and are suitable for pre-clinical in vivo use.

Abstract

This protocol describes recombinant adeno-associated virus (rAAV) production and purification by iodixanol density gradient centrifugation, a serotype-agnostic method of purifying AAV first described in 1999. rAAV vectors are widely used in gene therapy applications to deliver transgenes to various human cell types. In this work, the recombinant virus is produced by transfection of Expi293 cells in suspension culture with plasmids encoding the transgene, vector capsid, and adenoviral helper genes. Iodixanol density gradient centrifugation purifies full AAV particles based on particle density. Additionally, three steps are included in this now-ubiquitous methodology in order to increase total virus yield, decrease the risk of precipitation due to contaminating proteins, and further concentrate the final virus product, respectively: precipitation of viral particles from cell media using a solution of polyethylene glycol (PEG) and sodium chloride, the introduction of a second round of iodixanol density gradient centrifugation, and buffer exchange via a centrifugal filter. Using this method, it is possible to consistently achieve titers in the range of 1012 viral particles/mL of exceptional purity for in vivo use.

Introduction

Recombinant adeno-associated viral (rAAV) vectors are widely used tools for the treatment of genetic diseases, including spinal muscular atrophy, retinal dystrophy, and hemophilia A1,2,3. rAAV vectors are engineered to lack viral genes present in wild-type AAV4, a small, non-envelope icosahedral virus with a linear single-stranded 4.7 kb DNA genome. AAV was first discovered in the 1960s as a contaminant of adenovirus preparations5. Despite its small capsid size, which limits the size of the transgene that can be packaged to a ma....

Protocol

The composition of the solutions and buffers used in this protocol are provided in Table 1.

SolutionComposition
AAV lysis buffer1.2 mL of 5 M NaCl solution
2 mL of 1 M Tris-HCl pH 8.5 solution
80 uL of .......

Representative Results

This method can be used to obtain titers of at least 1012 viral particles per mL. A titer can be obtained (Figure 3) by qPCR using the ITR primers provided in Supplementary Table 1, by ddPCR, or by any other titering method. Suboptimal titers could result from using a cap gene encoding a capsid with poor packaging efficiency.

Another possible source of suboptimal results is the poor transduction efficiency of Expi293 cells. It .......

Discussion

The double iodixanol density gradient purification protocol is the universal method because it is applicable to any AAV mutant variants, regardless of their receptor specificity. Early methods of AAV purification relied on particle density and included isopycnic centrifugation in CsCl and continuous sucrose density gradient centrifugation19. Later, serotype-specific approaches were developed, which made use of monoclonal antibodies bound to Sepharose columns20. A novel dens.......

Acknowledgements

None.

....

Materials

NameCompanyCatalog NumberComments
5810 R benchtop centrifugeEppendorf22625501
8-channel peristaltic pump Watson-Marlow020.3708.00A
Automated cell counter NanoEntekEVE-MC
Avanti J-E high-speed centrifugeBeckman Coulter369001
BenzonaseThermo Scientific88701
Biological safety cabinetLabconco322491101
CO2 incubator with shaker Set at 8% CO2 and 37 °C
Conical centrifuge tubesThermo Scientific33965250 mL
Conical centrifuge tubesThermo Scientific33965015 mL
Disposable micro-pipetsFisherbrand21-164-2GCapillaries
Dulbecco's phosphate buffered saline without CaCl2 and MgCl2  (DPBS) (10x)Sigma-AldrichD1408
ECLIPSE Ts2R-FL inverted microscopeNikon
Expi293 Expression MediumGibcoA1435101
Expi293F cellsGibcoA14527
Filter tipsUSA Scientific1126-78101000 µL
Filter tipsUSA Scientific1120-8810200 µL
Filter tipsUSA Scientific1120-181020 µL
Filter tipsUSA Scientific1121-381010 µL
Hypodermic needlesTyco Healthcare82011220 GA x 1-1/2 A
Ice bucket with lidVWR10146-184
JS-5.3 rotorBeckman Coulter368690
Magnesium chloride solution (1 M)Millipore SigmaM1028-100ML
Metal stand and clamp Fisherbrand05-769-6Q
Microcentrifuge tubesEppendorf226000281.5 mL
Needle nose pliers
Optima XE-90 ultracentrifugeBeckman CoulterA94471
Opti-MEM I Reduced-Serum MediumGibco31985062
OptiPrep density gradient media (iodixanol)SerumwerkAXS-111454260% iodixanol solution
P1000 PipetGilsonF144059M
P2 PipetGilsonF144054M
P20 PipetGilsonF144056M
P200 PipetGilsonF144058M
Phenol red solutionSigma-AldrichP0290
Phosphate buffered saline (PBS)Sigma-AldrichP4474
Pipet-Aid XP pipette controllerDrummond Scientific4-000-101
Plasmid pCapsidDe novo or Addgene, etc. N/AWe used pACGrh74. 
Plasmid pHelperAddgene112867
Plasmid pTransgeneDe novo or Addgene, etc. N/AWe used pdsAAV-GFP.
Pluronic F-68 polyol solution (10%)Mp Biomedicals92750049
Polyethylene glycol 8000Research Products InternationalP48080-500.0
Polyethylenimine HCl Max (PEI-Max)PolysciencesNC1038561Dilute in water to 40 μM
Polypropylene centrifuge tubes, sterileCorning431123500 mL
Polypropylene centrifuge tubes, sterileCorning430776250 mL
Polypropylene Optiseal tubesBeckman Coulter361625
Serological pipettesAlkali ScientificSP250-B50 mL
Serological pipettesAlkali ScientificSP225-B25 mL
Serological pipettesAlkali ScientificSP210-B10 mL
Serological pipettesAlkali ScientificSP205-B5 mL
Shaker flasksFisherbrandPBV10001 L
Shaker flasksFisherbrandPBV50-0500 mL
Shaker flasksFisherbrandPBV250250 mL
Shaker flasksFisherbrandPBV12-5125 mL
Sodium chloride solution (5 M)Fisher ScientificNC1752640
Sterile syringesFisherbrand14-955-4585 mL
Syringe filterMilliporeSLGV013SL0.22 micron
Tris-HCl pH 8.5 (1 M)Kd MedicalRGE3363
Trypan blue solutionGibco15250061
Tube rack assemblyBeckman Coulter361646
Tube spacers (x4)Beckman Coulter361669
Tubing for peristaltic pumpFisher Scientific14190516
Type 70 Ti fixed-angle titanium rotorBeckman Coulter337922
Ultra low temperature freezerSet at -70 °C
Vivaspin 20 centrifugal concentratorSartoriusVS2041
Water bath Set at 37 °C

References

  1. Strauss, K. A., et al. Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial. Nat Med. 28 (7), 1390-1397 (2022).
  2. Fuller-Carter, P. I., Basiri, H., Harvey, A. R., Carvalho, L. S.

Explore More Articles

Adeno associated VirusAAVGene TherapyIodixanol Density Gradient CentrifugationRecombinant AAVSuspension CultureExpi293 CellsPEG PrecipitationBuffer ExchangeVirus PurificationVirus ProductionVirus YieldIn Vivo Applications

This article has been published

Video Coming Soon

JoVE Logo

Riservatezza

Condizioni di utilizzo

Politiche

Ricerca

Didattica

CHI SIAMO

Copyright © 2025 MyJoVE Corporation. Tutti i diritti riservati